Preclinical studies indicated that intraperitoneal administration of anti-carcinoembryonic antigen (CEA) chimeric antigen receptor (CAR)-T cells provided better efficacy against colon cancer peritoneal metastasis than systemic administration. The gene discussed is CEACAM5; the disease is malignant colon neoplasm.